Skip to main content
. 2018 Sep 8;67(1):55–65. doi: 10.1007/s00005-018-0523-9

Fig. 3.

Fig. 3

The percentage of CD19+/CD5+/TLR2+ in CLL patients depending on ZAP-70 (a) and CD38 expression (b)